Search research articles
Contact Us
Filters
Showing results (1201-1210 of 1,237) with videos related to
Page
of 124
Sort By:
Circulation. Arrhythmia and Electrophysiology
|
January 20, 2016
Outcome of Apparently Unexplained Cardiac Arrest: Results From Investigation and Follow-Up of the Prospective Cardiac Arrest Survivors With Preserved Ejection Fraction Registry
Adam R M Herman, Christopher Cheung, Brenda Gerull, et al.
International Journal of Radiation Oncology, Biology, Physics
|
June 19, 2013
Phase 2 study of erlotinib combined with adjuvant chemoradiation and chemotherapy in patients with resectable pancreatic cancer
Joseph M Herman, Katherine Y Fan, Aaron T Wild, et al.
Blood
|
November 14, 2022
NRX-0492 degrades wild-type and C481 mutant BTK and demonstrates in vivo activity in CLL patient-derived xenografts
Deyi Zhang, Hailey M Harris, Jonathan Chen, et al.
Blood
|
January 8, 2025
Potentiating CD20 monoclonal antibody therapy by targeting complement C3 fragments covalently deposited on lymphoma cells
Sivasubramanian Baskar, Haiyong Peng, Erika M Gaglione, et al.
JAMA Surgery
|
July 13, 2017
Association of Clinical Factors With a Major Pathologic Response Following Preoperative Therapy for Pancreatic Ductal Adenocarcinoma
Jordan M Cloyd, Huamin Wang, Michael E Egger, et al.
Journal of Radiation Oncology
|
March 11, 2015
Resection of borderline resectable pancreatic cancer after neoadjuvant chemoradiation does not depend on improved radiographic appearance of tumor-vessel relationships
Avani S Dholakia, Amy Hacker-Prietz, Aaron T Wild, et al.
Science Advances
|
December 4, 2024
Interferon response and epigenetic modulation by <i>SMARCA4</i> mutations drive ovarian tumor immunogenicity
Melica Nourmoussavi Brodeur, Higinio Dopeso, Yingjie Zhu, et al.
International Journal of Radiation Oncology, Biology, Physics
|
November 7, 2024
NRG Oncology International Consensus Contouring Atlas on Target Volumes and Dosing Strategies for Dose-Escalated Pancreatic Cancer Radiation Therapy
Nina N Sanford, Amol K Narang, Todd A Aguilera, et al.
Molecular Cancer Research : MCR
|
August 29, 2013
The twist box domain is required for Twist1-induced prostate cancer metastasis
Rajendra P Gajula, Sivarajan T Chettiar, Russell D Williams, et al.
Cancer
|
December 25, 2014
Phase 2 multi-institutional trial evaluating gemcitabine and stereotactic body radiotherapy for patients with locally advanced unresectable pancreatic adenocarcinoma
Joseph M Herman, Daniel T Chang, Karyn A Goodman, et al.
Page
of 124
Search research articles
Search
Showing results (1201-1210 of 1,237) with videos related to
Sort By:
Page
of 124
Circulation. Arrhythmia and Electrophysiology
|
January 20, 2016
Outcome of Apparently Unexplained Cardiac Arrest: Results From Investigation and Follow-Up of the Prospective Cardiac Arrest Survivors With Preserved Ejection Fraction Registry
Adam R M Herman, Christopher Cheung, Brenda Gerull, et al.
International Journal of Radiation Oncology, Biology, Physics
|
June 19, 2013
Phase 2 study of erlotinib combined with adjuvant chemoradiation and chemotherapy in patients with resectable pancreatic cancer
Joseph M Herman, Katherine Y Fan, Aaron T Wild, et al.
Blood
|
November 14, 2022
NRX-0492 degrades wild-type and C481 mutant BTK and demonstrates in vivo activity in CLL patient-derived xenografts
Deyi Zhang, Hailey M Harris, Jonathan Chen, et al.
Blood
|
January 8, 2025
Potentiating CD20 monoclonal antibody therapy by targeting complement C3 fragments covalently deposited on lymphoma cells
Sivasubramanian Baskar, Haiyong Peng, Erika M Gaglione, et al.
JAMA Surgery
|
July 13, 2017
Association of Clinical Factors With a Major Pathologic Response Following Preoperative Therapy for Pancreatic Ductal Adenocarcinoma
Jordan M Cloyd, Huamin Wang, Michael E Egger, et al.
Journal of Radiation Oncology
|
March 11, 2015
Resection of borderline resectable pancreatic cancer after neoadjuvant chemoradiation does not depend on improved radiographic appearance of tumor-vessel relationships
Avani S Dholakia, Amy Hacker-Prietz, Aaron T Wild, et al.
Science Advances
|
December 4, 2024
Interferon response and epigenetic modulation by <i>SMARCA4</i> mutations drive ovarian tumor immunogenicity
Melica Nourmoussavi Brodeur, Higinio Dopeso, Yingjie Zhu, et al.
International Journal of Radiation Oncology, Biology, Physics
|
November 7, 2024
NRG Oncology International Consensus Contouring Atlas on Target Volumes and Dosing Strategies for Dose-Escalated Pancreatic Cancer Radiation Therapy
Nina N Sanford, Amol K Narang, Todd A Aguilera, et al.
Molecular Cancer Research : MCR
|
August 29, 2013
The twist box domain is required for Twist1-induced prostate cancer metastasis
Rajendra P Gajula, Sivarajan T Chettiar, Russell D Williams, et al.
Cancer
|
December 25, 2014
Phase 2 multi-institutional trial evaluating gemcitabine and stereotactic body radiotherapy for patients with locally advanced unresectable pancreatic adenocarcinoma
Joseph M Herman, Daniel T Chang, Karyn A Goodman, et al.
Page
of 124